1 0

    FDA FAERS Reports for Jounavax (Suzetrigine) – Jan 2023–Present

    FDA FAERS Reports for Jounavax (Suzetrigine) – Jan 2023–Present

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: I would like to request FDA FAERS reports on the drug Jounavax (generic name: suzetrigine) from January 1, 2023 - present. Please look for events under both brand and generic names. Where possible, please email the results in a PDF or Excel file. 
    Tags: Pharma, FAERS, 2023

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details